18000 STUDEBAKER RD, CERRITOS, CA
Starling Oncology Enters $25 Million Credit Agreement with Gemino Healthcare
Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
Rebrands as Starling Oncology
Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving Liquidity
2026 Annual Meeting of Stockholders - Proposals Voted by Shareholders
News
Reports First Quarter 2026 Financial Results
Annual Report to Security Holders
Q2
Q1
Q3
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Prospectus filed pursuant to Rule 424(b)(3)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence
Submission Upload